Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 12/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | CCKBR | P32239 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7068926 | 1.00 | TRPV1 (0.43) | TRPV1PPARGPPARACCKBRTLR8 | |
| SCHEMBL7069697 | 0.92 | PPARG (0.41) | TRPV1PPARGPPARACCKBRMEN1 | |
| SCHEMBL7069282 | 0.88 | PPARG (0.45) | PPARGPPARAPDE10ASCN9A | |
| SCHEMBL7068924 | 0.86 | PPARA (0.51) | TRPV1PPARGPPARACCKBR | |
| SCHEMBL7067696 | 0.86 | PPARA (0.51) | TRPV1PPARGPPARACCKBR | |
| SCHEMBL7068772 | 0.84 | PDE10A (0.42) | MEN1KMT2APDE10ASCN9A | |
| SCHEMBL7069687 | 0.83 | PDE10A (0.39) | TRPV1CCKBRTLR8MEN1KMT2A | |
| SCHEMBL7069876 | 0.83 | PPARG (0.43) | TRPV1PPARGPPARAPDE10A | |
| SCHEMBL7069510 | 0.83 | TRPV1 (0.41) | TRPV1PPARGPPARACCKBRMEN1 | |
| SCHEMBL7069751 | 0.82 | SCN9A (0.45) | TRPV1PDE10ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030212100-A1 | Quinoline derivatives and medicinal use thereof | MITSUI CHEMICALS, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212100-A1 | Quinoline derivatives and medicinal use thereof | PPARG, PPARD, PPARA | TRPV1 2301/4885PPARG 1/4885PPARA 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.